NUF2 and cancer: The cancer patients with higher expression of NDC80, NUF2, SPC24, and SPC25 were predicted to have worse OS, DFS, DFI, and PFI, which suggested that NDC80 complex components may be potential prognostic indicator molecules in pan-cancer (Figure 3).